粤公网安备 44011302004783号 Brand-new vaccine
投放时间: 2025-06-30 08:00:00
With your help, we can take steps to stay ahead of the next COVID-19 variant. Consider taking part in the VXA-COV-202 Study for an investigational vaccine that comes in tablet form. If you are at least 18 years old and have completed your primary COVID-19 shots, you may qualify for the VXA-COV-202 Study.
搜索关键词 COVID-19 vaccine study, tablet vaccine, VXA-COV-202, variant protection, medical research, vaccine clinical trial, adult vaccination, public health, new vaccine, easy to take vaccine优势 Tablet form for easy administration,Potential protection against future variants,Opportunity to contribute to medical research
展示估值
38301
热度
3389
最新发现时间
2025-06-30 08:00:00
投放天数
210
素材信息
素材类型
素材尺寸
主页ID8289873642118442897
主页名字BRCR Global
产品信息
适用范围
适用人群both
劣势Investigational vaccine - potential unknown side effects,Requires prior primary COVID-19 vaccination,Study participation - time commitment required
情感安心
人民币汇率走势
CNY
关注我们
新媒网跨境发布
本站原创内容版权归作者及NMedia共同所有，未经许可，禁止以任何形式转载。